Immunoneutralization of Growth Differentiation Factor 9 Reveals It Partially Accounts for Mouse Oocyte Mitogenic Activity

Paracrine factors secreted by oocytes play a pivotal role in promoting early ovarian follicle growth and in defining a morphogenic gradient in antral follicles, yet the exact identities of these oocyte factors remain unknown. This study was conducted to determine the extent to which the mitogenic ac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biology of reproduction 2004-09, Vol.71 (3), p.732-739
Hauptverfasser: GILCHRIST, R. B, RITTER, L. J, GROOME, N. P, RITVOS, O, CRANFIELD, M, JEFFERY, L. A, AMATO, F, SCOTT, S. J, MYLLYMAA, S, KAIVO-OJA, N, LANKINEN, H, MOTTERSHEAD, D. G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 739
container_issue 3
container_start_page 732
container_title Biology of reproduction
container_volume 71
creator GILCHRIST, R. B
RITTER, L. J
GROOME, N. P
RITVOS, O
CRANFIELD, M
JEFFERY, L. A
AMATO, F
SCOTT, S. J
MYLLYMAA, S
KAIVO-OJA, N
LANKINEN, H
MOTTERSHEAD, D. G
description Paracrine factors secreted by oocytes play a pivotal role in promoting early ovarian follicle growth and in defining a morphogenic gradient in antral follicles, yet the exact identities of these oocyte factors remain unknown. This study was conducted to determine the extent to which the mitogenic activity of mouse oocytes can be attributed to growth differentiation factor 9 (GDF9). To do this, specific anti-human GDF9 monoclonal antibodies were generated. Based on epitope mapping and bioassays, a GDF9 neutralizing antibody, mAb-GDF9-53, was characterized with very low cross-reactivity with related transforming growth factor (TGF)β superfamily members, including BMP15 (also called GDF9B). Pep-SPOT epitope mapping showed that mAb-GDF9-53 recognizes a short 4-aa sequence, and three-dimensional peptide modeling suggested that this binding motif lies at the C-terminal fingertip of mGDF9. As predicted by sequence alignments and modeling, the antibody detected recombinant GDF9, but not BMP15 in a Western blot and GDF9 protein in oocyte extract and oocyte-conditioned medium. In a mouse mural granulosa cell (MGC) bioassay, mAb-GDF9-53 completely abolished the mitogenic effects of GDF9, but had no effect on TGFβ1 or activin A-stimulated MGC proliferation. An unrelated IgG at the same dose had no effect on GDF9 activity. This GDF9 neutralizing antibody was then tested in an established oocyte-secreted mitogen bioassay, where denuded oocytes cocultured with granulosa cells promote cell proliferation in a dose-dependent manner. The mAb-GDF9-53 dose dependently (0–160 μg/ml) decreased the mitogenic activity of oocytes but only by ∼45% at the maximum dose of mAb. Just 5 μg/ml of mAb-GDF9-53 neutralized 90% of recombinant mGDF9 mitogenic activity, but only 15% of oocyte activity. Unlike mAb-GDF9-53, a TGFβ pan-specific neutralizing antibody did not affect the mitogenic capacity of the oocyte, but completely neutralized TGFβ1-induced DNA synthesis. This study has characterized a specific GDF9 neutralizing antibody. Our data provide the first direct evidence that the endogenous GDF9 protein is an important oocyte-secreted mitogen, but also show that GDF9 accounts for only part of total oocyte bioactivity.
doi_str_mv 10.1095/biolreprod.104.028852
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_66797727</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66797727</sourcerecordid><originalsourceid>FETCH-LOGICAL-h267t-e02596edb9721672eec5503fa80eab610296492427be76271ba02912655137b93</originalsourceid><addsrcrecordid>eNpFkV9r2zAUxcXoWLOuH2FDL-2bO_2xJOsxpG0aaMgY67ORletGw7Y6SY5xP_0ETbeny73nx-FwLkJfKbmhRIvvjfNdgJfg93kvbwirKsE-oAUVTBeKyeoMLQghsuBc8nP0OcbfhNCSM_4JnVNBWSW0WKB50_fj4AcYUzCdezXJ-QH7Fq-Dn9IB37q2hQBDcm_KvbHJB6zxTziC6SLeJPzDhCx33YyX1vpxSBG3mdn6MQLeeTsnwFuX_DMMzmYmuaNL8xf0sc0GcHmaF-jp_u7X6qF43K03q-VjcWBSpQIIE1rCvtGKUakYgBWC8NZUBEwjKWFalpqVTDWgJFO0MflEmRSCctVofoGu33xzV39GiKnuXbTQdWaAnLCWUmmlmMrgtxM4Nj3s65fgehPm-r2sDFydABOt6dpgBuvif06Skpc52z_u4J4PkwtQxz7Xk215PU2TojWvVX7EX1LziVI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66797727</pqid></control><display><type>article</type><title>Immunoneutralization of Growth Differentiation Factor 9 Reveals It Partially Accounts for Mouse Oocyte Mitogenic Activity</title><source>MEDLINE</source><source>EZB Electronic Journals Library</source><source>Oxford Journals</source><source>BioOne Complete</source><creator>GILCHRIST, R. B ; RITTER, L. J ; GROOME, N. P ; RITVOS, O ; CRANFIELD, M ; JEFFERY, L. A ; AMATO, F ; SCOTT, S. J ; MYLLYMAA, S ; KAIVO-OJA, N ; LANKINEN, H ; MOTTERSHEAD, D. G</creator><creatorcontrib>GILCHRIST, R. B ; RITTER, L. J ; GROOME, N. P ; RITVOS, O ; CRANFIELD, M ; JEFFERY, L. A ; AMATO, F ; SCOTT, S. J ; MYLLYMAA, S ; KAIVO-OJA, N ; LANKINEN, H ; MOTTERSHEAD, D. G</creatorcontrib><description>Paracrine factors secreted by oocytes play a pivotal role in promoting early ovarian follicle growth and in defining a morphogenic gradient in antral follicles, yet the exact identities of these oocyte factors remain unknown. This study was conducted to determine the extent to which the mitogenic activity of mouse oocytes can be attributed to growth differentiation factor 9 (GDF9). To do this, specific anti-human GDF9 monoclonal antibodies were generated. Based on epitope mapping and bioassays, a GDF9 neutralizing antibody, mAb-GDF9-53, was characterized with very low cross-reactivity with related transforming growth factor (TGF)β superfamily members, including BMP15 (also called GDF9B). Pep-SPOT epitope mapping showed that mAb-GDF9-53 recognizes a short 4-aa sequence, and three-dimensional peptide modeling suggested that this binding motif lies at the C-terminal fingertip of mGDF9. As predicted by sequence alignments and modeling, the antibody detected recombinant GDF9, but not BMP15 in a Western blot and GDF9 protein in oocyte extract and oocyte-conditioned medium. In a mouse mural granulosa cell (MGC) bioassay, mAb-GDF9-53 completely abolished the mitogenic effects of GDF9, but had no effect on TGFβ1 or activin A-stimulated MGC proliferation. An unrelated IgG at the same dose had no effect on GDF9 activity. This GDF9 neutralizing antibody was then tested in an established oocyte-secreted mitogen bioassay, where denuded oocytes cocultured with granulosa cells promote cell proliferation in a dose-dependent manner. The mAb-GDF9-53 dose dependently (0–160 μg/ml) decreased the mitogenic activity of oocytes but only by ∼45% at the maximum dose of mAb. Just 5 μg/ml of mAb-GDF9-53 neutralized 90% of recombinant mGDF9 mitogenic activity, but only 15% of oocyte activity. Unlike mAb-GDF9-53, a TGFβ pan-specific neutralizing antibody did not affect the mitogenic capacity of the oocyte, but completely neutralized TGFβ1-induced DNA synthesis. This study has characterized a specific GDF9 neutralizing antibody. Our data provide the first direct evidence that the endogenous GDF9 protein is an important oocyte-secreted mitogen, but also show that GDF9 accounts for only part of total oocyte bioactivity.</description><identifier>ISSN: 0006-3363</identifier><identifier>EISSN: 1529-7268</identifier><identifier>DOI: 10.1095/biolreprod.104.028852</identifier><identifier>PMID: 15128595</identifier><identifier>CODEN: BIREBV</identifier><language>eng</language><publisher>Madison, WI: Society for the Study of Reproduction</publisher><subject>Amino Acid Sequence ; Animals ; Antibodies, Monoclonal - pharmacology ; Biological and medical sciences ; Bone Morphogenetic Protein 15 ; Female ; Fundamental and applied biological sciences. Psychology ; Growth Differentiation Factor 9 ; Intercellular Signaling Peptides and Proteins - chemistry ; Intercellular Signaling Peptides and Proteins - immunology ; Intercellular Signaling Peptides and Proteins - metabolism ; Mammalian female genital system ; Mice ; Mitogens - chemistry ; Mitogens - immunology ; Mitogens - metabolism ; Molecular Sequence Data ; Morphology. Physiology ; Oocytes - cytology ; Oocytes - metabolism ; Protein Structure, Tertiary ; Transforming Growth Factor beta - genetics ; Transforming Growth Factor beta - immunology ; Transforming Growth Factor beta - metabolism ; Vertebrates: reproduction</subject><ispartof>Biology of reproduction, 2004-09, Vol.71 (3), p.732-739</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16043450$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15128595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GILCHRIST, R. B</creatorcontrib><creatorcontrib>RITTER, L. J</creatorcontrib><creatorcontrib>GROOME, N. P</creatorcontrib><creatorcontrib>RITVOS, O</creatorcontrib><creatorcontrib>CRANFIELD, M</creatorcontrib><creatorcontrib>JEFFERY, L. A</creatorcontrib><creatorcontrib>AMATO, F</creatorcontrib><creatorcontrib>SCOTT, S. J</creatorcontrib><creatorcontrib>MYLLYMAA, S</creatorcontrib><creatorcontrib>KAIVO-OJA, N</creatorcontrib><creatorcontrib>LANKINEN, H</creatorcontrib><creatorcontrib>MOTTERSHEAD, D. G</creatorcontrib><title>Immunoneutralization of Growth Differentiation Factor 9 Reveals It Partially Accounts for Mouse Oocyte Mitogenic Activity</title><title>Biology of reproduction</title><addtitle>Biol Reprod</addtitle><description>Paracrine factors secreted by oocytes play a pivotal role in promoting early ovarian follicle growth and in defining a morphogenic gradient in antral follicles, yet the exact identities of these oocyte factors remain unknown. This study was conducted to determine the extent to which the mitogenic activity of mouse oocytes can be attributed to growth differentiation factor 9 (GDF9). To do this, specific anti-human GDF9 monoclonal antibodies were generated. Based on epitope mapping and bioassays, a GDF9 neutralizing antibody, mAb-GDF9-53, was characterized with very low cross-reactivity with related transforming growth factor (TGF)β superfamily members, including BMP15 (also called GDF9B). Pep-SPOT epitope mapping showed that mAb-GDF9-53 recognizes a short 4-aa sequence, and three-dimensional peptide modeling suggested that this binding motif lies at the C-terminal fingertip of mGDF9. As predicted by sequence alignments and modeling, the antibody detected recombinant GDF9, but not BMP15 in a Western blot and GDF9 protein in oocyte extract and oocyte-conditioned medium. In a mouse mural granulosa cell (MGC) bioassay, mAb-GDF9-53 completely abolished the mitogenic effects of GDF9, but had no effect on TGFβ1 or activin A-stimulated MGC proliferation. An unrelated IgG at the same dose had no effect on GDF9 activity. This GDF9 neutralizing antibody was then tested in an established oocyte-secreted mitogen bioassay, where denuded oocytes cocultured with granulosa cells promote cell proliferation in a dose-dependent manner. The mAb-GDF9-53 dose dependently (0–160 μg/ml) decreased the mitogenic activity of oocytes but only by ∼45% at the maximum dose of mAb. Just 5 μg/ml of mAb-GDF9-53 neutralized 90% of recombinant mGDF9 mitogenic activity, but only 15% of oocyte activity. Unlike mAb-GDF9-53, a TGFβ pan-specific neutralizing antibody did not affect the mitogenic capacity of the oocyte, but completely neutralized TGFβ1-induced DNA synthesis. This study has characterized a specific GDF9 neutralizing antibody. Our data provide the first direct evidence that the endogenous GDF9 protein is an important oocyte-secreted mitogen, but also show that GDF9 accounts for only part of total oocyte bioactivity.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Antibodies, Monoclonal - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Bone Morphogenetic Protein 15</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Growth Differentiation Factor 9</subject><subject>Intercellular Signaling Peptides and Proteins - chemistry</subject><subject>Intercellular Signaling Peptides and Proteins - immunology</subject><subject>Intercellular Signaling Peptides and Proteins - metabolism</subject><subject>Mammalian female genital system</subject><subject>Mice</subject><subject>Mitogens - chemistry</subject><subject>Mitogens - immunology</subject><subject>Mitogens - metabolism</subject><subject>Molecular Sequence Data</subject><subject>Morphology. Physiology</subject><subject>Oocytes - cytology</subject><subject>Oocytes - metabolism</subject><subject>Protein Structure, Tertiary</subject><subject>Transforming Growth Factor beta - genetics</subject><subject>Transforming Growth Factor beta - immunology</subject><subject>Transforming Growth Factor beta - metabolism</subject><subject>Vertebrates: reproduction</subject><issn>0006-3363</issn><issn>1529-7268</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkV9r2zAUxcXoWLOuH2FDL-2bO_2xJOsxpG0aaMgY67ORletGw7Y6SY5xP_0ETbeny73nx-FwLkJfKbmhRIvvjfNdgJfg93kvbwirKsE-oAUVTBeKyeoMLQghsuBc8nP0OcbfhNCSM_4JnVNBWSW0WKB50_fj4AcYUzCdezXJ-QH7Fq-Dn9IB37q2hQBDcm_KvbHJB6zxTziC6SLeJPzDhCx33YyX1vpxSBG3mdn6MQLeeTsnwFuX_DMMzmYmuaNL8xf0sc0GcHmaF-jp_u7X6qF43K03q-VjcWBSpQIIE1rCvtGKUakYgBWC8NZUBEwjKWFalpqVTDWgJFO0MflEmRSCctVofoGu33xzV39GiKnuXbTQdWaAnLCWUmmlmMrgtxM4Nj3s65fgehPm-r2sDFydABOt6dpgBuvif06Skpc52z_u4J4PkwtQxz7Xk215PU2TojWvVX7EX1LziVI</recordid><startdate>20040901</startdate><enddate>20040901</enddate><creator>GILCHRIST, R. B</creator><creator>RITTER, L. J</creator><creator>GROOME, N. P</creator><creator>RITVOS, O</creator><creator>CRANFIELD, M</creator><creator>JEFFERY, L. A</creator><creator>AMATO, F</creator><creator>SCOTT, S. J</creator><creator>MYLLYMAA, S</creator><creator>KAIVO-OJA, N</creator><creator>LANKINEN, H</creator><creator>MOTTERSHEAD, D. G</creator><general>Society for the Study of Reproduction</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20040901</creationdate><title>Immunoneutralization of Growth Differentiation Factor 9 Reveals It Partially Accounts for Mouse Oocyte Mitogenic Activity</title><author>GILCHRIST, R. B ; RITTER, L. J ; GROOME, N. P ; RITVOS, O ; CRANFIELD, M ; JEFFERY, L. A ; AMATO, F ; SCOTT, S. J ; MYLLYMAA, S ; KAIVO-OJA, N ; LANKINEN, H ; MOTTERSHEAD, D. G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h267t-e02596edb9721672eec5503fa80eab610296492427be76271ba02912655137b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Antibodies, Monoclonal - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Bone Morphogenetic Protein 15</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Growth Differentiation Factor 9</topic><topic>Intercellular Signaling Peptides and Proteins - chemistry</topic><topic>Intercellular Signaling Peptides and Proteins - immunology</topic><topic>Intercellular Signaling Peptides and Proteins - metabolism</topic><topic>Mammalian female genital system</topic><topic>Mice</topic><topic>Mitogens - chemistry</topic><topic>Mitogens - immunology</topic><topic>Mitogens - metabolism</topic><topic>Molecular Sequence Data</topic><topic>Morphology. Physiology</topic><topic>Oocytes - cytology</topic><topic>Oocytes - metabolism</topic><topic>Protein Structure, Tertiary</topic><topic>Transforming Growth Factor beta - genetics</topic><topic>Transforming Growth Factor beta - immunology</topic><topic>Transforming Growth Factor beta - metabolism</topic><topic>Vertebrates: reproduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GILCHRIST, R. B</creatorcontrib><creatorcontrib>RITTER, L. J</creatorcontrib><creatorcontrib>GROOME, N. P</creatorcontrib><creatorcontrib>RITVOS, O</creatorcontrib><creatorcontrib>CRANFIELD, M</creatorcontrib><creatorcontrib>JEFFERY, L. A</creatorcontrib><creatorcontrib>AMATO, F</creatorcontrib><creatorcontrib>SCOTT, S. J</creatorcontrib><creatorcontrib>MYLLYMAA, S</creatorcontrib><creatorcontrib>KAIVO-OJA, N</creatorcontrib><creatorcontrib>LANKINEN, H</creatorcontrib><creatorcontrib>MOTTERSHEAD, D. G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Biology of reproduction</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GILCHRIST, R. B</au><au>RITTER, L. J</au><au>GROOME, N. P</au><au>RITVOS, O</au><au>CRANFIELD, M</au><au>JEFFERY, L. A</au><au>AMATO, F</au><au>SCOTT, S. J</au><au>MYLLYMAA, S</au><au>KAIVO-OJA, N</au><au>LANKINEN, H</au><au>MOTTERSHEAD, D. G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunoneutralization of Growth Differentiation Factor 9 Reveals It Partially Accounts for Mouse Oocyte Mitogenic Activity</atitle><jtitle>Biology of reproduction</jtitle><addtitle>Biol Reprod</addtitle><date>2004-09-01</date><risdate>2004</risdate><volume>71</volume><issue>3</issue><spage>732</spage><epage>739</epage><pages>732-739</pages><issn>0006-3363</issn><eissn>1529-7268</eissn><coden>BIREBV</coden><abstract>Paracrine factors secreted by oocytes play a pivotal role in promoting early ovarian follicle growth and in defining a morphogenic gradient in antral follicles, yet the exact identities of these oocyte factors remain unknown. This study was conducted to determine the extent to which the mitogenic activity of mouse oocytes can be attributed to growth differentiation factor 9 (GDF9). To do this, specific anti-human GDF9 monoclonal antibodies were generated. Based on epitope mapping and bioassays, a GDF9 neutralizing antibody, mAb-GDF9-53, was characterized with very low cross-reactivity with related transforming growth factor (TGF)β superfamily members, including BMP15 (also called GDF9B). Pep-SPOT epitope mapping showed that mAb-GDF9-53 recognizes a short 4-aa sequence, and three-dimensional peptide modeling suggested that this binding motif lies at the C-terminal fingertip of mGDF9. As predicted by sequence alignments and modeling, the antibody detected recombinant GDF9, but not BMP15 in a Western blot and GDF9 protein in oocyte extract and oocyte-conditioned medium. In a mouse mural granulosa cell (MGC) bioassay, mAb-GDF9-53 completely abolished the mitogenic effects of GDF9, but had no effect on TGFβ1 or activin A-stimulated MGC proliferation. An unrelated IgG at the same dose had no effect on GDF9 activity. This GDF9 neutralizing antibody was then tested in an established oocyte-secreted mitogen bioassay, where denuded oocytes cocultured with granulosa cells promote cell proliferation in a dose-dependent manner. The mAb-GDF9-53 dose dependently (0–160 μg/ml) decreased the mitogenic activity of oocytes but only by ∼45% at the maximum dose of mAb. Just 5 μg/ml of mAb-GDF9-53 neutralized 90% of recombinant mGDF9 mitogenic activity, but only 15% of oocyte activity. Unlike mAb-GDF9-53, a TGFβ pan-specific neutralizing antibody did not affect the mitogenic capacity of the oocyte, but completely neutralized TGFβ1-induced DNA synthesis. This study has characterized a specific GDF9 neutralizing antibody. Our data provide the first direct evidence that the endogenous GDF9 protein is an important oocyte-secreted mitogen, but also show that GDF9 accounts for only part of total oocyte bioactivity.</abstract><cop>Madison, WI</cop><pub>Society for the Study of Reproduction</pub><pmid>15128595</pmid><doi>10.1095/biolreprod.104.028852</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-3363
ispartof Biology of reproduction, 2004-09, Vol.71 (3), p.732-739
issn 0006-3363
1529-7268
language eng
recordid cdi_proquest_miscellaneous_66797727
source MEDLINE; EZB Electronic Journals Library; Oxford Journals; BioOne Complete
subjects Amino Acid Sequence
Animals
Antibodies, Monoclonal - pharmacology
Biological and medical sciences
Bone Morphogenetic Protein 15
Female
Fundamental and applied biological sciences. Psychology
Growth Differentiation Factor 9
Intercellular Signaling Peptides and Proteins - chemistry
Intercellular Signaling Peptides and Proteins - immunology
Intercellular Signaling Peptides and Proteins - metabolism
Mammalian female genital system
Mice
Mitogens - chemistry
Mitogens - immunology
Mitogens - metabolism
Molecular Sequence Data
Morphology. Physiology
Oocytes - cytology
Oocytes - metabolism
Protein Structure, Tertiary
Transforming Growth Factor beta - genetics
Transforming Growth Factor beta - immunology
Transforming Growth Factor beta - metabolism
Vertebrates: reproduction
title Immunoneutralization of Growth Differentiation Factor 9 Reveals It Partially Accounts for Mouse Oocyte Mitogenic Activity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T20%3A47%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunoneutralization%20of%20Growth%20Differentiation%20Factor%209%20Reveals%20It%20Partially%20Accounts%20for%20Mouse%20Oocyte%20Mitogenic%20Activity&rft.jtitle=Biology%20of%20reproduction&rft.au=GILCHRIST,%20R.%20B&rft.date=2004-09-01&rft.volume=71&rft.issue=3&rft.spage=732&rft.epage=739&rft.pages=732-739&rft.issn=0006-3363&rft.eissn=1529-7268&rft.coden=BIREBV&rft_id=info:doi/10.1095/biolreprod.104.028852&rft_dat=%3Cproquest_pubme%3E66797727%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66797727&rft_id=info:pmid/15128595&rfr_iscdi=true